EXOZYMES INC. (EXOZ)
2025-06-30 | 2025-03-31 | |||
|---|---|---|---|---|
| Total operating income | - | - | ||
| Research and development costs, net | 802,991 | 575,016 | ||
| Professional fees | 368,932 | 532,235 | ||
| General and administrative-other | 265,449 | 204,236 | ||
| Compensation | 1,068,838 | 613,924 | ||
| Information technology | 41,835 | 25,317 | ||
| Total general and administrative costs | 1,745,054 | 1,375,712 | ||
| Total operating costs | 2,548,045 | 1,950,728 | ||
| Net operating loss | -2,548,045 | -1,950,728 | ||
| Interest income/ (expense) | 76,557 | 94,307 | ||
| Other income | 111,202 | - | ||
| Loss before income taxes | -2,360,286 | -1,856,421 | ||
| Income taxes | - | - | ||
| Net loss | -2,360,286 | -1,856,421 | ||
| Net loss per common share - basic | -0.28 | -0.22 | ||
| Net loss per common share - diluted | -0.28 | -0.22 | ||
| Weighted average of common shares outstanding - basic | 8,377,265 | 8,367,810 | ||
| Weighted average of common shares outstanding - diluted | 8,377,265 | 8,367,810 | ||